Enalare Therapeutics Inc Profile last edited on: 10/19/23
CAGE: 8G2D2
UEI: MDJFW877BCV6
Business Identifier: Novel therapies for life-threatening acute respiratory and critical care conditions. 
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
Location Information
Location: Single
Congr. District: 12
County: Mercer
Congr. District: 12
County: Mercer
Public Profile
Extracted word for word from firm's website - no idi input: "Enalare Therapeutics is a privately owned clinical-stage biopharmaceutical company dedicated to developing novel therapies for patients suffering from acute respiratory conditions. We have assembled a talented team with extensive pharmaceutical experience across all critical functions, focused on advancing our innovative products through development, regulatory review and launch."
Extent of SBIR involvement
Synopsis: Awardee Business Condition
Employee Range
5-9Revenue Range
.5M-1MVC funded?
NoPublic/Private
Privately HeldStock Info
----IP Holdings
1-4Awards Distribution by Agency
Most Recent SBIR Projects
| Year | Phase | Agency | Total Amount | |
|---|---|---|---|---|
| 2022 | 1 | NIH | $319,703 | |
| Project Title: Development of medication for the treatment of respiratory depression due to opioid (prescribed or illicit) overdose/multidrug (polysubstance) overdose in a hospital or community setting. | ||||
Key People / Management
Dan Motto
Joseph Pergolizzi
Joseph Pergolizzi
Company News
There are no news available.
